Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Gero named a 2026 WEF Technology Pioneer for its physics-first AI platform advancing aging science and drug discovery.

(Siarhei_Fetisenkov/Creatas Video+/Getty Images Plus) An eagerly awaited and controversial clinical trial to 'wind back the ...

NewLimit’s lead liver combo has proven its worth in preclinical models, Kimmel told Fierce, with the ability to boost ...

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called pro-aging metabolic reprogramming (PAMRP), which could change our ...

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called Pro-Aging Metabolic Reprogramming (PAMRP), which could change our ...